CVE-2026-43574 — MEDIUM (6.5)

Q: How severe is CVE-2026-43574?

CVE-2026-43574 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2026-43574?

Check the references section above for vendor advisories and patch information. Affected products include: Openclaw Openclaw.

Vulnerability Description

OpenClaw before 2026.4.12 contains an improper authorization vulnerability in helper-backed channels where empty resolved approver lists are interpreted as explicit approval authorization. Attackers can resolve pending approvals without proper authorization by exploiting this logic flaw if they know an approval id.

CVSS Score

6.5

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

NONE

Integrity

HIGH

Availability

NONE

Affected Products

Vendor	Product	Versions
Openclaw	Openclaw	< 2026.4.12

Related Weaknesses (CWE)

CWE-183

References

https://github.com/openclaw/openclaw/commit/0a105c0900de701d2ee9f1abc96b017afbd0Patch
https://github.com/openclaw/openclaw/security/advisories/GHSA-49cg-279w-m73xVendor Advisory
https://www.vulncheck.com/advisories/openclaw-improper-authorization-via-empty-aThird Party Advisory

FAQ

What is CVE-2026-43574?

CVE-2026-43574 is a vulnerability with a CVSS score of 6.5 (MEDIUM). OpenClaw before 2026.4.12 contains an improper authorization vulnerability in helper-backed channels where empty resolved approver lists are interpreted as explicit approval authorization. Attackers c...

How severe is CVE-2026-43574?

CVE-2026-43574 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-43574?

Check the references section above for vendor advisories and patch information. Affected products include: Openclaw Openclaw.